Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Ostrowski, Sisse R ^a   Pedersen, Sune H ^b   Jensen, Jan S ^b,c   Mogelvang, Rasmus ^a   Johansson, Pär I ^a,d  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; CATECHOLAMINE; CLOPIDOGREL; HEPARIN; HYPERTENSIVE AGENT; NORADRENALIN; SYNDECAN 1; THROMBOMODULIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; CAUSE OF DEATH; CELL DAMAGE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; GLYCOCALYX; HAZARD RATIO; HEART FAILURE; HOSPITAL ADMINISTRATOR; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORADRENALIN BLOOD LEVEL; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84874059320     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12532     Document Type: Article

References (43)

1. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 1980, 303:436-444. 10.1056/NEJM198008213030806, 6248784.
2. Dunser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009, 24:293-316. 10.1177/0885066609340519, 19703817.
3. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009, 54:1747-1762. 10.1016/j.jacc.2009.05.015, 19874988.
4. Johansson PI, Ostrowski SR. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses 2010, 75:564-567. 10.1016/j.mehy.2010.07.031, 20708846.
5. Makhmudov RM, Mamedov Y, Dolgov VV, Repin VS. Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa 1985, 27:456-463.
6. Kristova V, Kriska M, Canova R, Hejdova E, Kobzova D, Dobrocky P. Endothelial changes following repeated effect of vasoconstrictive substances in vitro. Acta Physiol Hung 1993, 81:363-370.
7. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 2012, 72:428-436.
8. Ostrowski SR, Sørensen AM, Windeløv NA, Perner A, Welling KL, Wanscher M, Larsen CF, Johansson PI. High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation. Scand J Trauma Resusc Emerg Med 2012, 20:27. 10.1186/1757-7241-20-27, 3352319, 22490186.
9. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011, 254:194-200. 10.1097/SLA.0b013e318226113d, 21772125.
10. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906. 10.1161/CIRCULATIONAHA.106.684852, 17923576.
11. Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 1981, 102:24-29. 10.1016/0002-8703(81)90408-7, 7246410.
12. Richardt G, Munch G, Neumann FJ, Rauch B, Kurz T. Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction. Basic Res Cardiol 1997, 92:52-60.
13. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000, 65:357-369. 10.1034/j.1600-0609.2000.065006357.x, 11168493.
14. Hawkey CM, Britton BJ, Wood WG, Peele M, Irving MH. Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 1975, 29:377-384. 10.1111/j.1365-2141.1975.tb01835.x, 1191556.
15. Sefrin P. Catecholamines in the serum of multiple trauma patients--mediators of ARDS?. Prog Clin Biol Res 1987, 236:477-486.
16. van der PT, Levi M, Dentener M, Jansen PM, Coyle SM, Braxton CC, Buurman WA, Hack CE, ten Cate JW, Lowry SF. Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 1997, 185:1143-1148. 10.1084/jem.185.6.1143, 2196238, 9091588.
17. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009, 17:45. 10.1186/1757-7241-17-45, 2758824, 19775458.
18. Ostrowski SR, Sorensen AM, Larsen CF, Johansson PI. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study. Scand J Trauma Resusc Emerg Med 2011, 19:64. 10.1186/1757-7241-19-64, 3212903, 22029598.
19. Schochl H, Cadamuro J, Seidl S, Franz A, Solomon C, Schlimp CJ, Ziegler B. Hyperfibrinolysis is common in out-of-hospital cardiac arrest: Results from a prospective observational thromboelastometry study. Resuscitation 2012, doi: 10.1016/j.resuscitation.2012.08.318.
20. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. Intensive Care Med 2000, 26:38-44. 10.1007/s001340050009, 10663278.
21. Grundmann S, Fink K, Rabadzhieva L, Bourgeois N, Schwab T, Moser M, Bode C, Busch HJ. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 2012, 83:715-720. 10.1016/j.resuscitation.2012.01.028, 22306259.
22. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87:300-310. 10.1093/cvr/cvq137, 20462866.
23. Salmon AH, Satchell SC. Endothelial glycocalyx dysfunction in disease: albuminuria and altered microvascular permeability. J Pathol 2012, 226:562-574. 10.1002/path.3964, 22102407.
24. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777. 10.1182/blood-2002-06-1887, 12543869.
25. Haywood-Watson R, Pati S, Kozar R, Faz J, Holcomb JB, Gonzalez E. Human micro-vascular barrier disruption after hemorrhagic shock. J Surg Res 2010, 158:313.
26. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 2011, 112:1289-1295. 10.1213/ANE.0b013e318210385c, 3102787, 21346161.
27. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS ONE 2011, 6:e23530. 10.1371/journal.pone.0023530, 3158765, 21886795.
28. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991, 65:618-623.
29. Blann A, Seigneur M. Soluble markers of endothelial cell function. Clin Hemorheol Microcirc 1997, 17:3-11.
30. Boffa MC. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker?. Haemostasis 1996, 26(Suppl 4):233-243.
31. Lindberg S, Pedersen SH, Mogelvang R, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, Jensen JS. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2012, 109:492-496. 10.1016/j.amjcard.2011.09.041, 22105783.
32. Aird WC. Endothelium as an organ system. Crit Care Med 2004, 32:S271-S279. 10.1097/01.CCM.0000129669.21649.40, 15118530.
33. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, Kastelein JJ, Stroes ES. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006, 55:480-486. 10.2337/diabetes.55.02.06.db05-1103, 16443784.
34. Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom AR, Juneja H, Chambless LE, Wu KK. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet 1999, 353:1729-1734. 10.1016/S0140-6736(98)09057-6, 10347984.
35. Blann AD, McCollum CN, Lip GY. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002, 13:513-518. 10.1097/00001721-200209000-00006, 12192303.
36. Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993, 71:423-431. 10.1016/0049-3848(93)90116-6, 8134903.
37. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol 1993, 72:255-259. 10.1016/0002-9149(93)90669-4, 8342501.
38. Katayama T, Nakashima H, Furudono S, Honda Y, Suzuki S, Yano K. Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction. Intern Med 2004, 43:1015-1022. 10.2169/internalmedicine.43.1015, 15609694.
39. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, Waring MT, Chicoine AT, van der Laan AM, Niessen HWM, Piek JJ, Rubin BB, Butany J, Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, Pittet MJ, Libby P, et al. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329. 10.1038/nature11260, 3401326, 22763456.
40. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986, 293:917-922.
41. Leineweber K, Heusch G. Beta 1-and beta 2-adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol 2009, 158:61-69. 10.1111/j.1476-5381.2009.00187.x, 2795234, 19422376.
42. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996, 94:690-697. 10.1161/01.CIR.94.4.690, 8772689.
43. Hartmann F, Kurowski V, Maghsoudi A, Kurz T, Schwarz M, Bonnemeier H, Tolg R, Jain D, Wiegand U, Katus H, Richardt G. Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction undergoing primary angioplasty. Relation to left ventricular function and clinical outcome. Z Kardiol 2003, 92:73-81. 10.1007/s00392-003-0885-8, 12545304.